MAA
ONCE

Managed Account Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Managed Account Advisors’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$17K Buy
291
+140
+93% +$9.26K ﹤0.01% 2824
2015
Q1 		$12K Buy
+151
New +$8.7K ﹤0.01% 2812

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Managed Account Advisors's ONCE Position: Q2 2015 in Review

Managed Account Advisors increased its Spark Therapeutics, Inc. Common Stock (ONCE) stake by 93% in Q2 2015, buying an estimated $9.26K and bringing the position to 291 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #2824.

Managed Account Advisors first reported a position in ONCE in Q1 2015 and has held it in 2 quarters since. 109 funds tracked by Wall St. Rank hold ONCE as of Q2 2015.

  • Managed Account Advisors held 291 shares of Spark Therapeutics, Inc. Common Stock worth $17K as of Q2 2015.
  • Managed Account Advisors bought 140 Spark Therapeutics, Inc. Common Stock shares in Q2 2015, an estimated $9.26K.
  • Spark Therapeutics, Inc. Common Stock made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2824 holding.
  • Managed Account Advisors first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and has held it in 2 quarters since.
  • 109 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.